Overview

Efficacy and Safety of Mydriatic Microdrops Compared With Standard Drops for Retinopathy of Prematurity (ROP) Screening: a Pilot Randomized Clinical Trial

Status:
Completed

Trial end date:
2020-09-29

Target enrollment:

Participant gender:

Summary

The purpose is to assess whether the use of microdrop instillation of phenylephrine 1.67% and tropicamide 0.33% maintains mydriatic efficacy while presents an improved safety profile compared with standard drops of phenylephrine 1.67% and tropicamide 0.33%, which is routine care for pupil dilation during retinopathy of prematurity (ROP) screening in our neonatal intensive care unit.

Phase:

Phase 4

Details

Lead Sponsor:

Aristotle University Of Thessaloniki

Treatments:

Oxymetazoline
Phenylephrine
Tropicamide